TGF-Beta Induced Key Genes of Osteogenic and Adipogenic Differentiation in Human Mesenchymal Stem Cells and

Genfa Du1, Xinyuan Cheng2, Zhen Zhang1

  • 1Department of Orthopedics, Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine, Guangzhou University of Chinese Medicine, Shenzhen, China.

Frontiers in Genetics
|December 13, 2021
PubMed

Insights

This study identifies key genes and miRNAs regulating human bone marrow mesenchymal stem cell differentiation, offering new therapeutic targets for osteoporosis and obesity by understanding the switch between bone formation and fat storage.

Area of Science:

  • Biomedical Science
  • Molecular Biology
  • Stem Cell Research

Background:

  • Osteoporosis treatment efficacy is limited, with no established gold standard.
  • A shift in human bone marrow mesenchymal stem cells (hMSCs) from osteogenic to adipogenic differentiation is linked to osteoporosis.
  • Understanding the molecular mechanisms driving this differentiation switch is crucial for developing new therapies.

Purpose of the Study:

  • To elucidate the biological mechanisms underlying the osteogenic and adipogenic differentiation of hMSCs.
  • To identify key genes and microRNAs (miRNAs) involved in these differentiation processes.
  • To provide novel insights for the prevention and treatment of osteoporosis and potentially obesity.

Main Methods:

  • Utilized microarray and bioinformatics analyses to identify differentially expressed genes (DEGs) in hMSCs.
  • Constructed protein-protein interaction (PPI) networks to identify hub genes.
  • Developed miRNA-mRNA interaction networks to analyze regulatory relationships.

Main Results:

  • Identified 98 upregulated genes promoting osteogenesis and 66 downregulated genes promoting adipogenesis.
  • Pinpointed key hub genes for osteogenesis (e.g., CTGF, IGF1, BMP2) and adipogenesis (e.g., PPARG, CEBPA).
  • Discovered specific miRNAs (e.g., hsa-miR-27a/b-3p, hsa-miR-128-3p) that co-regulate both differentiation pathways.

Conclusions:

  • Upregulated hub genes are potential therapeutic targets for promoting osteogenic differentiation.
  • Downregulated hub genes may serve as targets for inhibiting adipogenic differentiation.
  • Identified hub genes and miRNAs are critical regulators of hMSC differentiation, relevant to osteoporosis and obesity treatment.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
8.0K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.2K
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.8K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.1K